Toshiaki Suguro

484 total citations
12 papers, 415 citations indexed

About

Toshiaki Suguro is a scholar working on Surgery, Pharmacology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Toshiaki Suguro has authored 12 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 8 papers in Pharmacology and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Toshiaki Suguro's work include Cardiovascular, Neuropeptides, and Oxidative Stress Research (10 papers), Apelin-related biomedical research (8 papers) and Hormonal Regulation and Hypertension (7 papers). Toshiaki Suguro is often cited by papers focused on Cardiovascular, Neuropeptides, and Oxidative Stress Research (10 papers), Apelin-related biomedical research (8 papers) and Hormonal Regulation and Hypertension (7 papers). Toshiaki Suguro collaborates with scholars based in Japan and United States. Toshiaki Suguro's co-authors include Takuya Watanabe, Mitsuru Adachi, Akira Miyazaki, Tsutomu Hirano, Shigeki Hongo, Tomoko Kanome, Yuichiro SAKAMOTO, Tamio Hagiwara, Takatoshi Koyama and Masayoshi Shichiri and has published in prestigious journals such as Hypertension, Atherosclerosis and Current Medicinal Chemistry.

In The Last Decade

Toshiaki Suguro

12 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toshiaki Suguro Japan 9 357 291 189 144 31 12 415
S. Baillot-Rudoni France 11 161 0.5× 65 0.2× 76 0.4× 226 1.6× 49 1.6× 22 327
Haruhiko Hatakeyama Japan 13 225 0.6× 92 0.3× 148 0.8× 548 3.8× 146 4.7× 17 645
Alessandra Chiuch Italy 7 384 1.1× 47 0.2× 175 0.9× 502 3.5× 48 1.5× 9 633
Iku Kumaki Japan 4 431 1.2× 497 1.7× 124 0.7× 134 0.9× 42 1.4× 7 589
Bjørn Jørgensen Norway 7 191 0.5× 109 0.4× 140 0.7× 12 0.1× 23 0.7× 9 351
Marek Rosiak Poland 13 78 0.2× 76 0.3× 155 0.8× 65 0.5× 63 2.0× 33 328
Gianfranco Pasini Italy 6 62 0.2× 66 0.2× 330 1.7× 180 1.3× 28 0.9× 7 379
A.D. Flapan United Kingdom 6 231 0.6× 246 0.8× 99 0.5× 63 0.4× 21 0.7× 14 335
Ayumi Kadowaki Japan 3 192 0.5× 237 0.8× 65 0.3× 70 0.5× 35 1.1× 6 306
Isam Sharif United Kingdom 6 72 0.2× 61 0.2× 57 0.3× 106 0.7× 45 1.5× 8 214

Countries citing papers authored by Toshiaki Suguro

Since Specialization
Citations

This map shows the geographic impact of Toshiaki Suguro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshiaki Suguro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshiaki Suguro more than expected).

Fields of papers citing papers by Toshiaki Suguro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshiaki Suguro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshiaki Suguro. The network helps show where Toshiaki Suguro may publish in the future.

Co-authorship network of co-authors of Toshiaki Suguro

This figure shows the co-authorship network connecting the top 25 collaborators of Toshiaki Suguro. A scholar is included among the top collaborators of Toshiaki Suguro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshiaki Suguro. Toshiaki Suguro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Sato, Kengo, et al.. (2010). Serum levels and urinary excretion of salusin-α in renal insufficiency. Regulatory Peptides. 162(1-3). 129–132. 24 indexed citations
2.
Watanabe, Takuya, et al.. (2009). Human Urotensin II Promotes Hypertension and Atherosclerotic Cardiovascular Diseases. Current Medicinal Chemistry. 16(5). 550–563. 45 indexed citations
3.
Ban, Yoshiyuki, Takuya Watanabe, Toshiaki Suguro, et al.. (2009). Increased Plasma Urotensin-II and Carotid Atherosclerosis are Associated with Vascular Dementia. Journal of Atherosclerosis and Thrombosis. 16(3). 179–187. 31 indexed citations
4.
Watanabe, Takuya, Toshiaki Suguro, Masaharu Nagashima, et al.. (2008). Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice. Journal of Hypertension. 26(10). 1955–1965. 25 indexed citations
5.
Watanabe, Takuya, Tomoko Kanome, Toshiaki Suguro, & Akira Miyazaki. (2008). Human Urotensin II and Metabolic Syndrome. Vascular Disease Prevention. 3(1). 91–98. 2 indexed citations
6.
Watanabe, Takuya, Toshiaki Suguro, Kengo Sato, et al.. (2008). Serum Salusin-.ALPHA. Levels Are Decreased and Correlated Negatively with Carotid Atherosclerosis in Essential Hypertensive Patients. Hypertension Research. 31(3). 463–468. 54 indexed citations
7.
Suguro, Toshiaki, Takuya Watanabe, Gang Xu, et al.. (2008). Increased plasma urotensin-II levels are associated with diabetic retinopathy and carotid atherosclerosis in Type 2 diabetes. Clinical Science. 115(11). 327–334. 33 indexed citations
8.
Suguro, Toshiaki, et al.. (2007). Increased Human Urotensin II Levels Are Correlated With Carotid Atherosclerosis in Essential Hypertension. American Journal of Hypertension. 20(2). 211–217. 68 indexed citations
9.
Kanome, Tomoko, et al.. (2006). Human Urotensin II and Metabolic Syndrome. Vascular Disease Prevention. 3(2). 91–98. 3 indexed citations
10.
Hayashi, Toshiyuki, et al.. (2006). [Small dense LDL concentration is closely associated with serum apolipoprotein B, comparisons of non-LDL cholesterol or LDL cholesterol].. PubMed. 54(6). 569–75. 5 indexed citations
11.
Watanabe, Takuya, Toshiaki Suguro, Tomoko Kanome, et al.. (2005). Human Urotensin II Accelerates Foam Cell Formation in Human Monocyte-Derived Macrophages. Hypertension. 46(4). 738–744. 95 indexed citations
12.
Suguro, Toshiaki, Takuya Watanabe, Tomoko Kanome, et al.. (2005). Serotonin acts as an up-regulator of acyl-coenzyme A:cholesterol acyltransferase-1 in human monocyte–macrophages. Atherosclerosis. 186(2). 275–281. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Baillot-Rudoni Breakdown of academic impact, for papers by Haruhiko Hatakeyama Breakdown of academic impact, for papers by Alessandra Chiuch Breakdown of academic impact, for papers by Iku Kumaki Breakdown of academic impact, for papers by Bjørn Jørgensen Breakdown of academic impact, for papers by Marek Rosiak Breakdown of academic impact, for papers by Gianfranco Pasini Breakdown of academic impact, for papers by A.D. Flapan Breakdown of academic impact, for papers by Ayumi Kadowaki Breakdown of academic impact, for papers by Isam Sharif
Rankless by CCL
2026